Roxana Khorrami
Optometrist · Los Angeles, CANPI 1528476546
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Alcon at 33.9% of the total. Reporting peaked in 2019 at $796 and has fallen 98.0% since, to $16 in 2025.
Across 53 payments — averaging $30.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$545
- AbbVie$208
- Sun Pharmaceutical Industries Inc.$193
- Optos, Inc.$117
- Johnson & Johnson Surgical Vision, Inc.$115
- Shire North American Group Inc$110
- plus $320 from 11 others
What the payments were for
- Food & beverage$1,608100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 6 | $545 |
| AbbVie(2 entities) | 18 | $208 |
| Sun Pharmaceutical Industries Inc. | 5 | $193 |
| Optos, Inc. | 1 | $117 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $115 |
| Shire North American Group Inc | 5 | $110 |
| Novartis | 3 | $54 |
| Merz Pharmaceuticals, LLC | 2 | $51 |
| Harrow Eye, LLC | 2 | $37 |
| Johnson & Johnson Vision Care, Inc. | 1 | $31 |
| Oyster Point Pharma, Inc. | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $21 |
| Bausch & Lomb Americas Inc. | 1 | $20 |
| Omeros Corporation | 1 | $19 |
| Glaukos Corporation | 1 | $19 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hydrus Microstent$143
- PanOptix$140
- Precision 1$122
- P200DTx$117
- P200T$117
- P200TE$117
- P200TxE$117
- CEQUA$109
How this compares
$1,608 in reported general payments places this provider in the 70th percentile of 6,778 optometrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MoxifloxacinMoxifloxacin Hcl | 438 | $10,727 |
| Difluprednate | 24 | $2,541 |
| Prednisolone Acetate | 24 | $666 |
| Ketorolac Tromethamine | 13 | $390 |
| Brimonidine Tartrate | 18 | $96 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Los Angeles
- Cindy WuLos Angeles$136K
- Bogard ChangLos Angeles$53K
- Marian MasoudLos Angeles$36K
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.